Our latest COVID-19 information - full Autumn programme of webinars now in place
  • Home
  • Medical Device Regulation in the Eurasian Union, Russia and the CIS

Medical Device Regulation in the Eurasian Union, Russia and the CIS Training Course

A comprehensive overview of medical device regulatory affairs in Russia and the Eurasian Union. Key countries covered include Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan and Ukraine.

6-7 Oct 2021

& 13-14 Oct 2021

Book now


About this programme

The aim of this event is to provide a comprehensive overview of medical device regulatory affairs in Russia and the Eurasian Union. This interactive course will cover the regulatory requirements within these regions, focusing on practical aspects to assist in developing your regulatory strategy for product approval. The presentations will also give practical hints on the regulatory and registration process where possible.

Benefits of attending

Attending this programme will:
  • Give you the full background to the CIS medical device market
  • Ensure that you understand the full implications of the new regulations which will affect how you do business in the Eurasian Economic Union (EAEU)
  • Help clarify the document requirements and timelines of national procedures and EAEU registration procedures
  • Fully update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries

Who should attend?

This seminar will be of particular interest to:
  • Personnel working in medical device regulatory affairs in this region
  • Anyone who is considering marketing a medical device in this region
  • Those interested in an update on recent developments


Anna Harrington-Morozova (More...)

Anna Harrington-Morozova is a regulatory, drug development and external relations professional with over 20 years’ experience gained working in a Regulatory Authority, academia and industry. Anna graduated in Russia as a pharmacist. After working in the Russian Ministry of Health and the Clinical Pharmacology Department of
Moscow Medical University, she held regulatory and external relation positions in the pharmaceutical industry and CROs in Russia and the UK, including senior regulatory affairs posts in GSK,EISAI, ICON and PRA. Anna currently acts a a Scientific and Reguatory director at Regem Consulting Ltd – a consultancy which focuses on drug development, global regulatory advice, professional trainings and flexible resourcing solutions for the pharmaceutical, biotech and medical device industries in emerging markets.

Book now

Book now

6-7 Oct 2021
Live webinar
6-7 Oct 2021
Live webinar
GBP 1,099.00
EUR 1,579.00
USD 1,786.00
Until 25 Aug 21*
Enrol now
to attend
Live webinar
13-14 Oct 2021
Face-to-face, (venue not yet confirmed)
13-14 Oct 2021
(venue not yet confirmed)
GBP 1,299.00
EUR 1,819.00
USD 2,026.00
Until 1 Sep 21*
Enrol now
to attend
(venue not yet confirmed)
  • 2 days of classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • Abbott Diabetes Care
  • ArjoHuntleigh AB
  • Biomet UK Healthcare Ltd
  • Biotronik AG
  • Brainlab AG
  • Cepheid
  • Fidia Farmaceutici S.p.A.
  • HemoCue AB
  • Horus Pharma
  • Mölnlycke Health Care AB
  • Research and Markets
  • Santen Oy
  • Septodont
  • William Cook Europe ApS


Helen Finn, Regulatory Affairs Coordinator, ArjoHuntleigh, Oct 17

Content is very good. Speakers are also well prepared and competent

Anette Hulstrøm, Specialist Regulatory Affairs, William Cook Europe ApS, Oct 17